Executive Wealth Management LLC Raises Stake in DocuSign, Inc. (NASDAQ:DOCU)

→ The Long-Awaited End of America Update (From Stansberry Research) (Ad)

Executive Wealth Management LLC increased its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 88.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,977 shares of the company's stock after acquiring an additional 21,168 shares during the quarter. Executive Wealth Management LLC's holdings in DocuSign were worth $2,674,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of DOCU. Nelson Van Denburg & Campbell Wealth Management Group LLC grew its stake in DocuSign by 440.0% in the 1st quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 270 shares of the company's stock worth $28,000 after buying an additional 220 shares in the last quarter. McGlone Suttner Wealth Management Inc. purchased a new position in DocuSign in the 4th quarter worth approximately $32,000. Brown Brothers Harriman & Co. grew its stake in DocuSign by 381.9% in the 1st quarter. Brown Brothers Harriman & Co. now owns 559 shares of the company's stock worth $60,000 after buying an additional 443 shares in the last quarter. Farther Finance Advisors LLC grew its stake in DocuSign by 171.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 664 shares of the company's stock worth $34,000 after buying an additional 419 shares in the last quarter. Finally, Tyler Stone Wealth Management purchased a new position in DocuSign in the 2nd quarter worth approximately $36,000. 77.64% of the stock is currently owned by institutional investors.


DocuSign Stock Performance

NASDAQ:DOCU traded down $0.89 during midday trading on Wednesday, reaching $59.25. 1,265,977 shares of the stock traded hands, compared to its average volume of 3,570,741. The company has a fifty day moving average of $55.35 and a 200 day moving average of $51.41. DocuSign, Inc. has a 12 month low of $38.11 and a 12 month high of $64.76. The stock has a market capitalization of $12.17 billion, a P/E ratio of 164.59, a PEG ratio of 5.22 and a beta of 0.89.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, March 7th. The company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.09 by $0.06. DocuSign had a net margin of 2.68% and a return on equity of 13.91%. The business had revenue of $712.39 million during the quarter, compared to analyst estimates of $698.05 million. On average, analysts predict that DocuSign, Inc. will post 0.86 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

DOCU has been the subject of a number of research reports. JMP Securities reaffirmed a "market outperform" rating and issued a $84.00 price objective on shares of DocuSign in a research note on Monday, January 22nd. Morgan Stanley raised shares of DocuSign from an "underweight" rating to an "equal weight" rating and upped their price objective for the company from $49.00 to $64.00 in a research note on Tuesday, January 16th. TheStreet raised shares of DocuSign from a "d+" rating to a "c-" rating in a research note on Tuesday, December 19th. Wells Fargo & Company cut their price objective on shares of DocuSign from $55.00 to $45.00 and set an "underweight" rating for the company in a research note on Monday, February 5th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $50.00 price objective on shares of DocuSign in a research note on Friday, January 12th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, DocuSign currently has a consensus rating of "Hold" and an average price target of $58.33.

View Our Latest Research Report on DocuSign

Insiders Place Their Bets

In other DocuSign news, CEO Allan C. Thygesen sold 7,680 shares of the company's stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares in the company, valued at approximately $6,847,964.09. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Allan C. Thygesen sold 7,680 shares of the stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $61.27, for a total value of $470,553.60. Following the completion of the transaction, the chief executive officer now directly owns 111,767 shares in the company, valued at approximately $6,847,964.09. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Teresa Briggs sold 499 shares of the stock in a transaction dated Thursday, February 29th. The stock was sold at an average price of $52.99, for a total transaction of $26,442.01. Following the completion of the transaction, the director now owns 6,169 shares of the company's stock, valued at $326,895.31. The disclosure for this sale can be found here. In the last ninety days, insiders sold 54,871 shares of company stock worth $3,176,199. 17.80% of the stock is currently owned by corporate insiders.

DocuSign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides DocuSign e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

See Also

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Should you invest $1,000 in DocuSign right now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: